Featured Research

from universities, journals, and other organizations

Pacifier Use May Lower Risk Of SIDS

Date:
March 13, 2007
Source:
Blackwell Publishing Ltd.
Summary:
The risk of Sudden Infant Death Syndrome (SIDS), the third leading cause of infant death, may be lowered through the use of a pacifier. According to an article in Nursing for Women's Health, neonatal health care practitioners should counsel new parents on the potential benefits of using a pacifier.

The risk of Sudden Infant Death Syndrome (SIDS), the third leading cause of infant death, may be lowered through the use of a pacifier. According to an article in Nursing for Women’s Health, neonatal health care practitioners should counsel new parents on the potential benefits of using a pacifier.

This advice follows the release of updated recommendations from the American Academy of Pediatrics (AAP) Task Force on SIDS, suggesting that pacifier use be encouraged for children less than one year of age. “It’s important to note that the AAP’s pacifier recommendations are not unique,” says author Elizabeth Damato, Ph.D., RN. “A variety of studies have indicated that pacifier use lowers the risk of SIDS, and several other countries have made similar recommendations.” She stresses, however, that parents must be counseled on how to use pacifiers safely.

“Pacifiers shouldn’t be used before the age of one month in breastfed infants to avoid the disruption of regular feeding habits,” says Damato. “Also, infants should not be forced to take a pacifier and parents should not reinsert it once the infant falls asleep.” Parents should also avoid using homemade pacifiers, avoid strings or cords to secure the pacifier to the child, and regularly clean and replace pacifiers.

Even though evidence is mounting that pacifiers help to prevent SIDS, no one knows why. “Because SIDS happens so rarely, it is difficult to do large-scale controlled studies to determine why pacifiers might help,” says Damato. “However, because the risk for serious side effects is greatly reduced if pacifiers are used properly, they are a safe and sensible option in the battle against SIDS.”


Story Source:

The above story is based on materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "Pacifier Use May Lower Risk Of SIDS." ScienceDaily. ScienceDaily, 13 March 2007. <www.sciencedaily.com/releases/2007/03/070312152207.htm>.
Blackwell Publishing Ltd.. (2007, March 13). Pacifier Use May Lower Risk Of SIDS. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/03/070312152207.htm
Blackwell Publishing Ltd.. "Pacifier Use May Lower Risk Of SIDS." ScienceDaily. www.sciencedaily.com/releases/2007/03/070312152207.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins